Abstracts tagged "cyclophosphamide and outcomes"

Abstract Number: 2747 • 2017 ACR/ARHP Annual Meeting
Long Term Follow-up of Behcet’s Syndrome Patients Treated with Cyclophosphamide
Mert Gurcan¹, Sinem Nihal Esatoglu¹, Vedat Hamuryudan¹, Caner Saygin², Didem Saygin³, Serdal Ugurlu⁴, Emire Seyahi¹, Melike Melikoglu¹, Izzet Fresko¹, Sebahattin Yurdakul¹, Hasan Yazici¹ and Gulen Hatemi¹, ¹Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Cleveland, OH, ³Internal Medicine, Department of Internal Medicine, Cleveland Clinic, Cleveland, Cleveland, OH, ⁴Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
Background/Purpose: Cyclophosphamide (CYC) remains an important treatment option for Behçet’s syndrome (BS) pts with life threatening conditions such as arterial aneurysms. However, several adverse events…
Abstract Number: 2645 • 2014 ACR/ARHP Annual Meeting
Long-Term Efficacy and Safety of Pulse Cyclophosphamide for Neuropsychiatric Systemic Lupus Erythematosus: A Two-Centre Experience
Antonis Fanouriakis¹, Cristina Pamfil², Laura O. Damian³, Ioana Felea³, Emmanuel Mihali⁴, Ileana Filipescu², Theofanis Karageorgas⁵, Prodromos Sidiropoulos⁶, Simona Rednic², George Bertsias^6,7 and Dimitrios Boumpas^5,7,8, ¹Rheumatology, Clinical Immunology and Allergy, University of Crete, Heraklion, Greece, ²Rheumatology, University of Medicine and Pharmacy, Cluj-Napoca, Romania, ³Rheumatology, Emergency Clinical County Hospital Cluj, Cluj-Napoca, Romania, ⁴Emergency Clinical County Hospital Cluj, Cluj-Napoca, Romania, ⁵Clinical Immunology and Rheumatology, "Attikon" University Hospital of Athens, Athens, Greece, ⁶Rheumatology, Clinical Immunology, and Allergy, University of Crete, Heraklion, Greece, ⁷Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas, Heraklion, Crete, Greece, ⁸Biomedical Research Foundation, Academy of Athens, Athens, Greece
Background/Purpose Cyclophosphamide (CYC) is often used in severe neuropsychiatric systemic lupus erythematosus. However, data on its use rely on small case series and a single…